Vanessa Biotech, Inc

First shipment of Shylicine is enroute for the UAE Clinical trial.

Back to the open positions
January 13, 2023 - Hamden, Connecticut

The first shipment of Shylicine intended for the UAE Clinical trial is now, officially, on the way to Dubai.

This is a significant accomplishment for our team and evidence of our capacity to quickly reproduce a high-quality drug for human ingestion.

We congratulate the entire team in Spain, Hungary and the US for a job well done despite these extremely trying times.

Stay connected

Subscribe to receive updates on our research, product development, and new initiatives.

You have the right to withdraw your consent by unsubscribing at any time.